SLC25A23 activators are specialized molecules designed to enhance the function of the SLC25A23 protein, a member of the solute carrier 25 (SLC25) family that is integral to the transport of ions and other solutes across the inner mitochondrial membrane. SLC25A23 specifically is implicated in the exchange of calcium and phosphate ions, which is crucial for various cellular processes including energy metabolism, signal transduction, and the maintenance of mitochondrial integrity and function. By increasing the activity of SLC25A23, these activators aim to promote the efficient transport of these ions, which in turn could affect the mitochondrial capacity to generate ATP and regulate intracellular calcium signaling. The activation could occur through a direct interaction with the protein, potentially leading to a conformational change that results in an increased transport rate or affinity for calcium and phosphate ions. Alternatively, activators may indirectly enhance SLC25A23 activity by upregulating its expression or by modulating the lipid environment of the mitochondrial membrane to favor the protein's optimal activity.
The pursuit of SLC25A23 activators begins with compound screening, where libraries of small molecules are assessed for their ability to increase the activity of SLC25A23. These compounds may be identified through their effects on mitochondrial calcium uptake or phosphate transport in isolated mitochondria or cellular models. Following the identification of promising activators, detailed mechanistic studies are conducted to elucidate how these molecules interact with SLC25A23. Such studies often involve a combination of biochemical assays to measure the transport activity of SLC25A23 in the presence of potential activators, as well as biophysical approaches to determine the binding affinity and kinetics of these interactions.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid may upregulate SLC25A23 by binding to nuclear receptors which initiate transcriptional activation of genes including those related to mitochondrial function. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin could stimulate SLC25A23 expression by elevating cAMP, which in turn activates protein kinase A, leading to enhanced transcription of cAMP-responsive genes. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Cholecalciferol might upregulate SLC25A23 by engaging with the vitamin D receptor, prompting the transcription of genes that govern energy metabolism and calcium transport. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A may stimulate the expression of SLC25A23 by inhibiting histone deacetylase, which results in a more transcriptionally active chromatin state. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By causing DNA demethylation, 5-Azacytidine can increase the expression of genes that have been silenced by methylation, which could include SLC25A23. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol has the potential to upregulate SLC25A23 expression by activating sirtuins and modifying the activity of transcription factors that govern mitochondrial biogenesis. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium may induce SLC25A23 expression through inhibition of GSK-3, leading to the activation of transcription factors involved in mitochondrial protection and biogenesis. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate could increase SLC25A23 expression by enhancing histone acetylation, thereby promoting gene transcription linked to mitochondrial function and energy metabolism. | ||||||
Metformin-d6, Hydrochloride | 1185166-01-1 | sc-218701 sc-218701A sc-218701B | 1 mg 5 mg 10 mg | $292.00 $822.00 $1540.00 | 1 | |
Metformin is known to induce SLC25A23 by activating AMPK, which can shift cellular energy metabolism and stimulate the transcription of adaptive response genes. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Pioglitazone can stimulate SLC25A23 transcription by acting as a PPARγ agonist, which leads to an upregulation of genes involved in lipid and glucose metabolism. | ||||||